Assessment of depression and anxiety in patients with chronic liver disease
Abstract
Background/Aim. In recent years mental health of patients including those with chronic liver disease (CLD), has become interesting because its disturbance leads to reduced quality of life, that is associated with worsening of clinical outcome, reduced compliance and increased mortality. The aim of the study was to determinate the frequency and severity of depression and frequency of anxiety in patients with CLD and to assess the contribution of selected socio-demographic, clinical and laboratory risk factors for depression and anxiety. Methods. In this cross-sectional study, we used the Hamilton depression rating scale (HDRS) and Hamilton anxiety rating scale (HARS) in patients with CLD. Results. The study included 54 male and 43 female patients. Depression was present in 62.9%, and anxiety in 13.4% of the patients. A higher HDRS was noted in the patients older than 50 years (p = 0.022) and unemployed patients (p = 0.043). The patients with at least one episode of gastrointestinal bleeding had a significantly higher frequency of anxiety than those without bleeding (p = 0.018). A higher HARS score was present in the women (p = 0.011), unemployed patients (p = 0.008) and those with non-alcoholic liver disease (p = 0.007). There was a significant correlation between the mean corpuscular volume (MCV) and the value of the HDRS score, and between serum potassium and sodium levels and HDRS score. Conclusion. Age and the mean corpuscular volume have significant influence on the HDRS score while unemployment, gastrointestinal bleeding, serum potassium and serum sodium have predictive value for HARS score.
References
Lee K, Otgonsuren M, Younoszai Z, Mir HM, Younossi ZM. Asso-ciation of chronic liver disease with depression: a population-based study. Psychosomatics 2013; 4(1): 52−9.
Häuser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol 2004; 2(2): 157−63.
Miotto EC, Campanholo KR, Machado MA, Benute GG, Lucia MC, Fráguas R, et al. Cognitive performance and mood in patients on the waiting list for liver transplantation and their relation to the model for end-stage liver disease. Arq Neuropsiquiatr 2010; 68(1): 62−6.
Bianchi G, Marchesini G, Nicolino F, Graziani R, Sgarbi D, Loguercio C, et al. Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis 2005; 37(8): 593−600.
Orrù GM, Pariante CM. Depression and liver diseases. Dig Liver Dis 2005; 37(8): 564−5.
Aghanwa HS, Ndububa D. Specific psychiatric morbidity in liver cirrhosis in a Nigerian general hospital setting. Gen Hosp Psy-chiatry 2002; 24(6): 436−41.
Singh N, Gayowski T, Wagener MM, Marino IR. Depression in patients with cirrhosis. Impact on outcome. Dig Dis Sci 1997; 42(7): 1421−7.
Corruble E, Barry C, Varescon I, Falissard B, Castaing D, Samuel D. Depressive symptoms predict long-term mortality after liver transplantation. J Psychosom Res 2011; 71(1): 32−7.
Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000; 95(3): 760−7.
Bunzel B, Laederach-Hofmann K. Solid organ transplantation: are there predictors for posttransplant noncompliance? A litera-ture overview. Transplantation 2000; 70(5): 711−6.
Gutteling JJ, Duivenvoorden HJ, Busschbach JJ, de Man RA, Darlington AE. Psychological determinants of health-related quality of life in patients with chronic liver disease. Psychosomatics 2010; 51(2): 157−65.
Weinstein AA, Kallman PJ, Stepanova M, Poms LW, Fang Y, Moon J, et al. Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics 2011; 52(2): 127−32.
Navinés R, Castellví P, Moreno-España J, Gimenez D, Udina M, Cañizares S, et al. Depressive and anxiety disorders in chronic hepatitis C patients: reliability and validity of the Patient Health Questionnaire. J Affect Disord 2012; 138(3): 343−51.
Rocca P, Cocuzza E, Rasetti R, Rocca G, Zanalda E, Bogetto F. Predictors of psychiatric disorders in liver transplantation candidates: logistic regression models. Liver Transpl 2003; 9(7): 721−6.
Martins PD, Sankarankutty AK. Silva Ode C, Gorayeb R. Psy-chological distress in patients listed for liver transplantation. Acta Cir Bras 2006; 21(Suppl 1): 40−3.
Dogar I, Siddiqui N, Bajwa A, Bhatti A, Haider N, Hashmi ZY. Relationship between liver diseases and levels of anxiety and depression. J Pak Psych Soc 2009; 6(2): 61−4.
DiMartini A, Dew MA, Javed L, Fitzgerald MG, Jain A, Day N. Pretransplant psychiatric and medical comorbidity of alcoholic liver disease patients who received liver transplant. Psy-chosomatics 2004; 45(6): 517−23.
Popovic DD, Kovacevic NV, Kisic Tepavcevic DB, Trajkovic GZ, Alempijevic TM, Spuran MM, et al. Validation of the chronic liver disease questionnaire in Serbian patients. World J Ga-stroenterol 2013; 19(30): 4950−7.
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal va-rices. Br J Surg 1973; 60(8): 646−9.
Hamilton M. Development of a rating scale for primary de-pressive illness. Br J Soc Clin Psychol 1967; 6(4): 278−96.
Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32(1): 50−5.
Kraus MR, Schäfer A, Csef H, Scheurlen M, Faller H. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics 2000; 41(5): 377−84.
Lee DH, Jamal H, Regenstein FG, Perrillo RP. Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Dig Dis Sci 1997; 42(1): 186−91.
Gutteling JJ, de Man RA, Busschbach JJ, Darlington AE. Health-related quality of life and psychological correlates in patients listed for liver transplantation. Hepatol Int 2007; 1(4): 437−43.
Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological im-pairment in patients with chronic hepatitis C. Hepatology 2002; 35(2): 440−6.
Connor TJ, Leonard BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 1998; 62(7): 583−606.
Saunders JC. Neuropsychiatric symptoms of hepatitis C. Issues Ment Health Nurs 2008; 29(3): 209−20.
Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35(2): 433−9.
Goulding C, O'Connell P, Murray FE. Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol Hepatol 2001; 13(5): 507−11.
Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and functional disability in pa-tients with chronic hepatitis C. J Psychosom Res 2000; 49(5): 311−7.
Tillmann HL, Wiese M, Braun Y, Wiegand J, Tenckhoff S, Mössner J, et al. Quality of life in patients with various liver diseases: pa-tients with HCV show greater mental impairment, while pa-tients with PBC have greater physical impairment. J Viral He-pat 2011; 18(4): 252−61.
Martín-Santos R, Díez-Quevedo C, Castellví P, Navinés R, Miquel M, Masnou H, et al. De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C. Aliment Phar-macol Ther 2008; 27(3): 257−65.
Beloborodova EI, Lambrova EG, Beloborodova EV, Ostanko VL, Alekseeva AS, Kalacheva TP, et al. Somatopsychic manifestations in patients with chronic viral hepatitis. Klin Med (Mosk) 2010; 88(5): 42−5.
Shi X, Xun J, Wang S, Zhang J. Study on depression in 212 pa-tients with viral hepatitis. Zhonghua Liu Xing Bing Xue Za Zhi 2009; 30(10): 1060−4. (Chinese)
Surdea-Blaga T, Dumitraşcu DL. Depression and anxiety in nonalcoholic steatohepatitis: is there any association. Rom J Intern Med 2011; 49(4): 273−80.
Theofilou P. Depression and anxiety in patients with chronic renal failure: the effect of sociodemographic characteristics. Int J Nephrol 2011; 2011: 514070.
di Marco F, Verga M, Reggente M, Maria CF, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 2006; 100(10): 1767−74.
Parker G, Brotchie H. Gender differences in depression. Int Rev Psychiatry 2010; 22(5): 429−36.
Edwin D, Flynn L, Klein A, Thuluvath PJ. Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients. Hepatology 1999; 30(6): 1363−7.
Streisand RM, Rodrigue JR, Sears SF, Perri MG, Davis GL, Banko CG. A psychometric normative database for pre-liver transplantation evaluations. The Florida cohort 1991-1996. Psychosomatics 1999; 40(6): 479−85.
Ewusi-Mensah I, Saunders JB, Williams R. The clinical nature and detection of psychiatric disorders in patients with alcoholic liv-er disease. Alcohol Alcohol 1984; 19(4): 297−302.
Sarin SK, Sachdev G, Jiloha RC, Bhatt A, Munjal GC. Pattern of psychiatric morbidity and alcohol dependence in patients with alcoholic liver disease. Dig Dis Sci 1988; 33(4): 443−8.
Gledhill J, Burroughs A, Rolles K, Davidson B, Blizard B, Lloyd G. Psychiatric and social outcome following liver transplantation for alcoholic liver disease: a controlled study. J Psychosom Res 1999; 46(4): 359−68.
Eckardt MJ, File SE, Gessa GL, Grant KA, Guerri C, Hoffman PL, et al. Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res 1998; 22(5): 998−1040.
Alfonso-Loeches S, Guerri C. Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain. Crit Rev Clin Lab Sci 2011; 48(1): 19−47.
Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician 2009; 79(3): 203−8.
Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Ka-dowaki Y, et al. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 2001; 138(5): 332−7.
Reynolds EH. The neurology of folic acid deficiency. Handb Clin Neurol 2014; 120: 927−43.
Vogiatzoglou A, Smith A, Nurk E, Drevon CA, Ueland PM, Vollset SE, et al. Cognitive function in an elderly population: interac-tion between vitamin B12 status, depression, and apolipo-protein E ε4: the Hordaland Homocysteine Study. Psychosom Med 2013; 75(1): 20−9.
Huijts M, Duits A, Staals J, van Oostenbrugge RJ. Association of vitamin B12 deficiency with fatigue and depression after lacu-nar stroke. PLoS One 2012; 7(1): 30519.
Syed EU, Wasay M, Awan S. Vitamin B12 supplementation in treating major depressive disorder: a randomized controlled trial. Open Neurol J 2013; 7: 44−8.
Maes M, Van de Vyvere J, Vandoolaeghe E, Bril T, Demedts P, Wauters A, et al. Alterations in iron metabolism and the eryt-hron in major depression: further evidence for a chronic in-flammatory process. J Affect Disord 1996; 40(1−2): 23−33.
Alves de Rezende CH, Coelho LM, Oliveira LM, Penha SN. De-pendence of the geriatric depression scores on age, nutritional status, and haematologic variables in elderly institutionalized patients. J Nutr Health Aging 2009; 13(7): 617−21.
Krystal AD, Sutherland J, Hochman DW. Loop diuretics have an-xiolytic effects in rat models of conditioned anxiety. PLoS One 2012; 7(4): e35417.
Angeli P, Wong F, Watson H, Ginès P. Hyponatremia in cirrhosis: Results of a patient population survey. Hepatology 2006; 44(6): 1535−42.
Bengus A, Babiuc RD. Hyponatremia – predictor of adverse prognosis in cirrhosis. J Med Life 2012; 5(2): 176−8.
Sersté T, Gustot T, Rautou P, Francoz C, Njimi H, Durand F, et al. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. J Hepatol 2012; 57(2): 274−80.
Solà E, Watson H, Graupera I, Turón F, Barreto R, Rodríguez E, et al. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol 2012; 57(6): 1199−206.